Volume 150, Issue 3, Pages 597-605 (September 2016) Variation in Warfarin Use at Hospital Discharge After Isolated Bioprosthetic Mitral Valve Replacement Thomas A. Schwann, MD, Robert H. Habib, PhD, Rakesh M. Suri, MD, J. Matthew Brennan, MD, Xia He, MA, Vinod H. Thourani, MD, Milo Engoren, MD, Gorav Ailawadi, MD, Brian R. Englum, MD, Mark R. Bonnell, MD, James S. Gammie, MD CHEST Volume 150, Issue 3, Pages 597-605 (September 2016) DOI: 10.1016/j.chest.2016.04.015 Copyright © 2016 American College of Chest Physicians Terms and Conditions
Figure 1 Distribution of warfarin use across hospitals; A, All hospitals (N = 886). B, Hospitals with > 10 bioprosthetic mitral valve replacement (BMVR) cases annually (n = 245). CHEST 2016 150, 597-605DOI: (10.1016/j.chest.2016.04.015) Copyright © 2016 American College of Chest Physicians Terms and Conditions
Figure 2 Distribution of discharge warfarin rates across surgeons. A, All surgeons (N = 1,774). B, Surgeons with > 10 mitral valve replacement (MVR) cases annually (n = 172). CHEST 2016 150, 597-605DOI: (10.1016/j.chest.2016.04.015) Copyright © 2016 American College of Chest Physicians Terms and Conditions